Prolong Pharmaceuticals, LLC.

Headquartered in South Plainfield, New Jersey , Prolong Pharmaceuticals, LLC, is a clinical stage biopharmaceutical company focused on developing products to treat several diseases and their debilitating comorbidities associated with reduced quality of life, increased medical cost, and significant mortality. Prolong's senior management team includes inventors of the most successful drug-delivery technology in pharmaceutical history, PEGylation, which is now responsible for the development of a dozen drugs improving the quality of life for sufferers of hepatitis, kidney disease, and a number of other life-threatening diseases.